Clinical risk management of herb-drug interactions.
SourceBritish Journal of Clinical Pharmacology, 63, 3, (2007), pp. 258-267
Article / Letter to editor
Display more detailsDisplay less details
British Journal of Clinical Pharmacology
SubjectCTR 2: Clinical Pharmacology and physiology; EBP 4: Quality of Care; N4i 1: Pathogenesis and modulation of inflammation; N4i 3: Poverty-related infectious diseases; NCEBP 3: Implementation Science; UMCN 3.2: Cognitive neurosciences; CTR 2: Clinical Pharmacology and physiology
The concomitant use of conventional and herbal medicines can lead to clinically relevant herb-drug interactions. Clinical risk management offers a systematic approach to minimize the untoward consequences of these interactions by paying attention to: (i) risk identification and assessment; (ii) development and execution of risk reduction strategies; and (iii) evaluation of risk reduction strategies. This paper reviews which steps should be explored or taken in these domains to improve the clinical risk management of adverse herb-drug interactions.
Upload full text